Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Moderna, Inc. (MRNA)

NASDAQ

$145.54

$-3.36

(-2.25%)

Previous Close: ⁦$148.87⁩

Market Closed

Moderna, Inc. (MRNA) Live Price Chart

Last updated: ⁦2026-09-05 02:25:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $145.54, with a market capitalisation of $60.21B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.28 to $176.66. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$60.21B
Open	$153.62
Day's High	$1,420.00
Day's Low	$7.10
Previous Close	$148.87
Volume	14.13M
Average Volume	--
P/E Ratio	--
52-Week High	$176.66
52-Week Low	$22.28
Dividend Yield	--
Earnings Date	--

Moderna, Inc. (MRNA) Latest Closing Stock Price

Moderna, Inc. (MRNA) last closed at $148.87 as of 2026-09-05 00:01:00, unchanged from the previous close of $148.87.

During the latest regular trading session, MRNA traded between $7.10 and $1,420.00, with a volume of 14.13M shares. The closing price was near the lower end and near the upper end of its 52-week range.

Moderna, Inc. (MRNA) 7-Day Stock Price Change

Over the past seven days, Moderna, Inc. (MRNA) moved from $134.10 to $145.54, representing a gain of 8.53% ($11.44).

The stock traded between $141.67 and $157.16 during the period. The latest price is near the lower end of the 7-day range, indicating strong upward.

The average daily volume was 20.01 million shares, down versus the previous seven-day period, indicating lower trading activity.

MRNA 52-Week Price Position

Position in Range: 79.8%

52W Low$22.28

52W High$176.66

MRNA is currently trading at $145.54, placing it 79.8% of the way from its 52-week low of $22.28 to its 52-week high of $176.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Moderna, Inc. (MRNA)?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	4700
Exchange	NASDAQ
Company Website	https://www.modernatx.com

How to Buy Moderna, Inc. (MRNA) Stock on MEXC

Eligible investors can buy real shares of Moderna, Inc. (MRNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MRNA and Place Your Order

Open the RealStocks trading page and search for MRNA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Moderna, Inc. (MRNA) share price today?

Moderna, Inc. (MRNA) is currently trading at $ 145.54, down 2.24% ($3.33) from the previous close of $ 148.87. Intraday prices update in real time during regular trading hours.

2.Is MRNA stock going up or down today?

As of 2026-09-05 00:01:00, MRNA is trading at $ 145.54, down 2.24% ($3.33) from its previous close of $ 148.87. The stock has traded between $ 7.10 and $ 1,420.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MRNA pre-market price?

As of 2026-09-05 00:01:00, MRNA is trading at $ 154.71 in pre-market trading, up 3.92% ($5.84) from the previous close of $ 148.87. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MRNA after-hours price?

As of 2026-09-05 00:01:00, MRNA is trading at $ 145.00 in after-hours trading, down 2.60% ($3.87) from the regular-session close of $ 148.87. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is MRNA stock trading now?

MRNA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MRNA sit relative to its 52-week high and low?

Over the past 52 weeks, MRNA has traded between a low of $ 22.28 and a high of $ 176.66. At $ 145.54, the stock is positioned 79.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Moderna, Inc. in?

Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Moderna, Inc.'s market capitalisation and where is it listed?

Moderna, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 60.21B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MRNA valued in terms of P/E ratio and EPS?

MRNA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Moderna, Inc. pay a dividend?

Moderna, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.